Minocycline Hydrochloride
Sponsors
University of California, Davis, Ohio State University Comprehensive Cancer Center, Academic and Community Cancer Research United, Ranbaxy Laboratories Limited, Mahsa University
Conditions
Acute PainAnxiety DisorderBreast CarcinomaDepressionFragile X SyndromeHealthyHypertension, Resistant to Conventional TherapyPeriodontitis, Adult
Phase 2
Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer
CompletedNCT02203552
Start: 2015-06-23End: 2020-06-15Updated: 2025-01-08
Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel
CompletedNCT02297412
Start: 2014-11-30End: 2016-07-08Updated: 2022-01-31
Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury
Enrolling by invitationNCT05826912
Start: 2024-08-01End: 2029-08-31Target: 672Updated: 2025-12-22
Phase 4
Unknown Phase
Trial of Minocycline to Treat Children With Fragile X Syndrome
CompletedNCT01053156
Start: 2010-01-31End: 2011-12-31Updated: 2017-05-30
Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fasting Conditions
CompletedNCT02312297
Start: 2008-09-30End: 2008-12-31Updated: 2014-12-09
Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fed Conditions
CompletedNCT02312609
Start: 2008-09-30End: 2008-12-31Updated: 2014-12-09